Instructional Biology Inc. is a research-stage biotechnology company developing tools to understand biological signaling and translate evidence-based hypotheses into laboratory research. Its central platform, the Advanced Science AI Platform (ASAP), uses an evidence-weighted knowledge graph and hierarchical modeling to map relationships across peptides, receptors, signaling cascades, disease states, and outcomes. The system is designed to help researchers prioritize testable questions while making evidence, uncertainty, and human review visible.

The company describes its work as a connected stack of five technology systems: a protocol for preserving native biological material during processing; an optical pathogen-reduction system; an exosome-based carrier manufacturing system; ASAP’s reasoning system; and a therapeutic-regulation system intended for clinician-authorized, reviewed use. Its broader research thesis, Instructional Medicine, focuses on interpreting biological signals in context and exploring more individualized approaches to research and intervention. Instructional Biology also shares educational insights, including material on digital twins, bespoke therapeutics, and adaptive medicine. It invites research, clinical, and pharmaceutical organizations to discuss partnerships and licensing.